1 Probert, HM & Gibson, GR (2004) Development of a fermentation system to model sessile bacterial populations in the human colon. Biofilms 1, 13–19.
2 Harper, PH, Lee, EC, Kettlewell, MG, et al. (1985) Role of the faecal stream in the maintenance of Crohn's colitis. Gut 26, 279–284.
3 D'Haens, GR, Geboes, K, Peeters, M, et al. (1998) Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114, 262–267.
4 Gibson, GR & Roberfroid, MB (1995) Dietary modulation of the human colonic microbiota – introducing the concept of prebiotics. J Nutr 125, 1401–1412.
5 Cummings, JH, Christie, S & Cole, TJ (2001) A study of fructooligosaccharides in the prevention of travelers' diarrhea. Aliment Pharm Therap 8, 1139–1145.
6 Scheppach, W (1994) Effects of short chain fatty acids on gut morphology and function. Gut 35, S35–S38.
7 Cummings, JH & Englyst, HN (1987) Fermentation in the human large-intestine and the available substrates. Am J Clin Nutr 45, 1243–1255.
8 Saemann, MD, Bohmig, GA, Osterreicher, CH, et al. (2000) Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J 14, 2380–2382.
9 Cummings, JH & Macfarlane, GT (1991) The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 70, 443–459.
10 Macfarlane, GT, Gibson, GR & Cummings, JH (1992) Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 72, 57–64.
11 Hamaker, BR, Venkatachalam, M & Zhang, G, et al. (2007) .
12 Rose, DJ, Keshavarzian, A, Patterson, JA, et al. (2009) Starch-entrapped microspheres extend in vitro fecal fermentation, increase butyrate production, and change microbiota pattern. Mol Nutr Food Res 53, S121–S130.
13 Venema, K, Van Nuenen, HMC, Smeets-Peeters, MJE, et al. (2000) TNO's in vitro large intestinal model: an excellent screening tool for functional food and pharmaceutical research. Ernährung/Nutrition 24, 558–564.
14 Christl, SU, Katzenmaier, U, Hylla, S, et al. (1997) In vitro fermentation of high-amylose cornstarch by a mixed population of colonic bacteria. J Parenter Enteral Nutr 21, 290–295.
15 McBurney, MI & Thompson, LU (1989) Effect of human fecal donor on in vitro fermentation variables. Scand J Gastroenterol 24, 359–367.
16 Gibson, GR, Cummings, JH & Macfarlane, GT (1988) Use of a three-stage continuous culture system to study the effect of mucin on dissimilatory sulfate reduction and methanogenesis by mixed populations of human gut bacteria. Appl Environ Microbiol 54, 2750–2755.
17 Minekus, M, Smeets-Peeters, M, Bernalier, A, et al. (1999) A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol 53, 108–114.
18 Kovatcheva-Datchary, P, Egert, M, Maathuis, A, et al. (2009) Linking phylogenetic identities of bacteria to starch fermentation in an in vitro model of the large intestine by RNA-based stable isotope probing. Environ Microbiol 11, 914–926.
19 Jouany, JP (1982) Volatile fatty acids and alcohols determination in digestive contents, silage juice, bacterial culture and anaerobic fermenter contents. Sci Aliment 2, 131–144.
20 Maathuis, A, Hoffman, A, Evans, A, et al. (2010) The effect of the undigested fraction of maize products on the activity and composition of the microbiota determined in a dynamic in vitro model of the human large intestine. J Am Coll Nutr .
21 Stanco, G, Di Meo, C, Piccolo, G, et al. (2003) Effect of storage duration of frozen inoculums to be used for the in vitro gas production technique in rabbit. Ital J Anim Sci 2, 265–270.
22 Hervas, G, Frutos, P, Giraldez, FJ, et al. (2005) . Anim Feed Sci Technol , 107–118.
23 Mould, FL, Klien, KE, Morgan, R, et al. (2005) . Anim Feed Sci Technol , 31–50.
24 Goldin, BR & Gorbach, SL (1976) The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J Natl Cancer I 57, 371–375.
25 Thornton, JR (1981) High colonic pH promotes colorectal cancer. Lancet 1, 1081–1082.
26 Inan, MS, Rasoulpour, RJ, Yin, L, et al. (2000) The luminal short-chain fatty acid butyrate modulates NF-κB activity in a human colonic epithelial cell line. Gastroenterology 118, 724–734.
27 Luhrs, H, Gerke, T, Muller, JG, et al. (2002) Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 42, 788–796.
28 Packey, CD & Sartor, RB (2008) Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med 263, 597–606.
29 Loubinoux, J, Bronowicki, JP, Pereira, IA, et al. (2002) Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. Microbiol Ecol 40, 107–112.
30 Roediger, WE, Duncan, A, Kapaniris, O, et al. (1993) Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 104, 802–809.
31 Macfarlane, GT & McBain, AJ (1999) . In Colonic Microbiota, Nutrition and Health, pp. 1–26 [Gibson, GR and Roberfroid, MB, editors]. Dordrecht: Kulwer Academic Publishers.
32 Conway, PL (1997) . In Gastrointestinal Microbiology, pp. 3–38 [Mackie, RI, White, BA and Isaacson, RE, editors]. New York: Chapman & Hall.
33 Vernazza, CL, Rabiu, B & Gibson, G (2006) . In Prebiotics: Development & Application, pp. 1–28 [Gibson, GR and Rastall, RA, editors]. West Sussex: John Wiley & Sons, Ltd.
34 Seksik, P, Rigottier-Gois, L, Gramet, G, et al. (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52, 237–242.
35 Duncan, SH, Belenguer, A, Holtrop, G, et al. (2007) Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 73, 1073–1078.
36 Reynolds, JG, Silva, E & McCormack, WM (1983) Association of Streptococcus bovis with bowel disease. J Clin Microbiol 17, 696–697.
37 Leport, C, Bure, A, Leport, J, et al. (1987) Incidence of colonic lesions in Streptococcus bovis and enterococcal endocarditis. Lancet 1, 748.
38 Santos-Sierra, S, Golenbock, DT & Henneke, P (2006) Toll-like receptor-dependent discrimination of Streptococci. J Endotoxin Res 12, 307–312.
39 Sartor, RB (2005) Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 21, 44–50.
40 de Palencia, PF, Lopez, P, Corbi, AL, et al. (2008) Probiotic strains: survival under simulated gastrointestinal conditions, in vitro adhesion to Caco-2 cells and effect on cytokine secretion. Eur Food Res Technol 227, 1475–1484.
41 Freeman, HJ (2008) Recent developments on the role of Clostridium difficile in inflammatory bowel disease. World J Gastroenterol 14, 2794–2796.
42 Sartor, RB, Rath, HC & Sellon, RK (1996) Microbial factors in chronic intestinal inflammation. Curr Opin Gastroenterol 12, 327–333.
43 Mangin, I, Bonnet, R, Seksik, P, et al. (2004) Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol 50, 25–36.
44 Araki, Y, Andoh, A, Takizawa, J, et al. (2004) Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. Int J Mol Med 13, 577–580.
45 Darfeuille-Michaud, A, Boudeau, J, Bulois, P, et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412–421.
46 Onderdonk, AB, Richardson, JA, Hammer, RE, et al. (1998) Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun 66, 6022–6023.
47 Schultz, M (2008) Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm Bowel Dis 14, 1012–1018.
48 De, PV, Vanhoutte, T & Huys, G (2007) Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol 292, G358–G368.
49 Roberfroid, MB, Van Loo, JAE & Gibson, GR (1998) The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 128, 11–19.
50 Swidsinski, A, Weber, J, Loening-Baucke, V, et al. (2005) Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43, 3380–3389.
51 Bamba, T, Matsuda, H, Endo, M, et al. (1995) The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis. J Gastroenterol 30, 45–47.
52 Rogosa, M (1964) Genus Veillonella. I. General cultural, ecological, and biochemical considerations. J Bacteriol 87, 162–170.
53 Kim, SC, Tonkonogy, SL, Albright, CA, et al. (2005) Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128, 891–906.
54 Ohkusa, T, Okayasu, I, Ogihara, T, et al. (2003) Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 52, 79–83.